Research Article
Rewind for Posttraumatic Stress Disorder: A Randomised Controlled Trial
Table 3
Primary and secondary outcome results at 8- and 16-week follow-up for nonimputed data.
| | Immediate treatment group | Delayed treatment group | | Mean | SD | | Mean | SD |
| CAPS-5 symptom severity | Baseline | 20 | 36.50 | 8.24 | 20 | 40.15 | 5.77 | 8 weeks | 16 | 18.06 | 14.96 | 15 | 35.00 | 9.20 | 16 weeks | 17 | 16.94 | 14.51 | 9 | 21.33 | 12.99 | PCL-5 | Baseline | 20 | 52.65 | 11.56 | 19 | 57.21 | 12.31 | 8 weeks | 12 | 21.25 | 20.41 | 16 | 44.13 | 14.83 | 16 weeks | 10 | 24.50 | 24.29 | 7 | 23.71 | 21.68 | WSAS | Baseline | 19 | 21.16 | 9.44 | 18 | 23.39 | 9.85 | 8 weeks | 11 | 10.27 | 10.78 | 16 | 22.88 | 9.24 | 16 weeks | 9 | 14.67 | 13.36 | 6 | 13.50 | 13.82 | PHQ-9 | Baseline | 20 | 14.65 | 6.17 | 19 | 17.74 | 5.65 | 8 weeks | 12 | 5.58 | 6.72 | 16 | 15.06 | 6.14 | 16 weeks | 10 | 7.70 | 8.56 | 7 | 8.29 | 7.11 | GAD-7 | Baseline | 20 | 13.10 | 4.73 | 19 | 14.53 | 4.27 | 8 weeks | 12 | 5.75 | 6.20 | 16 | 12.69 | 4.85 | 16 weeks | 10 | 7.20 | 6.78 | 7 | 5.43 | 4.69 | ISI | Baseline | 20 | 17.65 | 5.96 | 19 | 19.00 | 6.21 | 8 weeks | 12 | 10.00 | 8.42 | 16 | 17.06 | 6.81 | 16 weeks | 10 | 11.00 | 10.85 | 7 | 12.57 | 5.32 | Audit-O | Baseline | 18 | 5.61 | 8.64 | 17 | 4.29 | 5.62 | 8 weeks | 11 | 4.36 | 6.12 | 16 | 4.25 | 4.84 | 16 weeks | 10 | 3.40 | 5.42 | 7 | 3.86 | 4.74 | MSPSS | Baseline | 20 | 56.75 | 15.95 | 19 | 54.89 | 15.81 | 8 weeks | 12 | 63.25 | 14.72 | 15 | 52.80 | 17.80 | 16 weeks | 10 | 64.00 | 16.81 | 7 | 54.43 | 22.10 |
|
|